Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Behavioral
Study Type: Observational
SUMMARY

Objectives: 1. To examine the variations in clinical features, survival outcomes, family history, and health behavior among proband patients who are known or suspected to have a hereditary colorectal cancer syndrome 2. To compare the clinical features, survival outcomes, and health behavior of the proband vs. his/her family members who may or may not be affected by the hereditary colorectal cancer syndrome 3. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in the overall disease phenotype across probands and kindreds, within a given syndrome. Disease phenotype is defined to include: (1) clinicopathologic features including patient demographics and oncologic outcomes; (2) clinical manifestations of disease including the timing, spectrum and severity of CRC and extracolonic cancers. Genetic variations may include the specific codon mutated, the type of mutation and sequence alteration (e.g. nonsense, missense etc), chromosomal/gene copy number changes, and gene polymorphisms. 4. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in somatic CRC tumor biology, including tumor pathology and other tumor molecular markers

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ Probands who meet the following criteria will be eligible:

• Patient must have or is suspected to have a hereditary CRC syndrome

• Patient must be at least 18 years of age at the time of study registration.

• Patient must have sufficient command of the English language and mental capacity to provide consent

⁃ Family members who meet the following criteria will be eligible:

• First- or second-degree relative of a registered MDACC patient who has met eligibility criteria for a Proband as defined above.

• Family member must be at least 18 years of age at the time of study registration.

• Family member must have sufficient command of the English language and mental capacity to provide consent

Locations
United States
Texas
University of Texas MD Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
Yi-Qian N. You, MD
YNYou@mdanderson.org
713-792-6940
Time Frame
Start Date: 2012-05-22
Estimated Completion Date: 2025-05-30
Participants
Target number of participants: 2000
Treatments
Consenting Proband Group
Questionnaires completed at baseline. Blood sample taken at baseline. Follow-up questionnaire completed at least 1 time in 5 years.
Family Members (MDA Registered Patients) Group
Health questionnaire completed at baseline. Blood sample taken at baseline. Follow-up questionnaire completed at least 1 time in 5 years.
Family Members (Not MDA Registered Patients) Group
Health questionnaire completed at baseline. Blood sample taken at baseline. Follow-up questionnaire completed at least 1 time in 5 years.
Sponsors
Leads: M.D. Anderson Cancer Center

This content was sourced from clinicaltrials.gov